Gi Windows, Inc.
Clinical trials sponsored by Gi Windows, Inc., explained in plain language.
-
New combo surgery shows promise for obesity and diabetes
Disease control CompletedThis study tested a surgery that combines stomach reduction with rerouting part of the small intestine to help people with obesity and type 2 diabetes lose weight and control blood sugar. 18 adults aged 19-65 with a BMI between 35 and 50 and stable diabetes took part. Researchers…
Phase: NA • Sponsor: GI Windows, Inc. • Aim: Disease control
Last updated Jun 03, 2026 12:06 UTC
-
Magnetic device aims to boost weight loss after failed surgery
Disease control CompletedThis study tested a new magnetic device that connects parts of the intestine to help people with severe obesity who didn't lose enough weight after a prior sleeve gastrectomy or gastric bypass. The goal was to see if the device is safe and works as intended. 28 adults took part, …
Phase: NA • Sponsor: GI Windows, Inc. • Aim: Disease control
Last updated Jun 02, 2026 11:58 UTC
-
Magnet magic: new device connects bowel without stitches
Disease control CompletedThis study tested a new magnetic device (Flexagon SFM plus OTOLoc) to connect two parts of the small bowel during keyhole surgery. 79 adults who needed this type of surgery took part. The main goal was to see if the device could create a successful connection without needing anot…
Phase: NA • Sponsor: GI Windows, Inc. • Aim: Disease control
Last updated May 19, 2026 12:00 UTC